Stiff person syndrome: Case series
Objective: To report and discuss three cases of Stiff Person Syndrome (SPS) with distinguished clinical features. Background: SPS is a rare disorder characterised by progressive…Nigrostriatal degeneration and serum BDNF levels in patients with “de novo” untreated Parkinson’s disease
Objective: To evaluate serum Brain-Derived NeurotrophicFactor(BDNF) levels in “de novo” untreated Parkinson's disease (PD) patients and their relationship to nigrostriatal degeneration measured with [123I]FP-CIT SPECT.…Multimodal imaging assessment of nigrostriatal pathway in Parkinson’s disease using 11C-PE2I PET and neuromelanin-sensitive MR
Objective: To evaluate the nigrostratal pathway with multimodal assessment using striatal 11C-PE2I PET and nigral Neuromelanin-sensitive MR in Parkinson's disease. Background: The main pathological features…Diffusion tensor imaging of the corticospinal tract differentiates Parkinson’s disease (PD) patients from controls
Objective: To asses white matter tractography of the corticospinal tract in PD patients. Background: Since the diagnosis of PD is still based on clinical assessment,…Frontal cortex grey matter integrity determines motor improvement after STN-DBS in patients with Parkinson’s disease
Objective: We hypothesize that the integrity of the cortical structures is an independent predictor for the DBS response. Background: Deep brain stimulation of subthalamic nucleus…Is it just a coincidence? Three new cases of Parkinson’s disease associated with myasthenia gravis
Objective: To introduce three new cases of Parkinson's disease (PD) patients who developed Myasthenia gravis (MG) and to review clinical features and diagnostic approaches of…Ultra high field magnetic resonance imaging of nigrosome 1 is a biomarker of new onset and premotor Parkinson’s disease
Objective: An unmet need exists to develop a methodology to diagnose Parkinson's disease (PD) in the premotor stage, so that patients can be enrolled in…Lessons-experienced in the creation of a global public-private consortium with the goal of advancing treatments that hold most potential for delayed disease progression in Parkinson’s disease – Critical path for Parkinson’s (CPP)
Objective: The path is summarized that led to the creation of a global public-private-partnership uniting an international non-profit charity, Parkinson's UK, a global non-profit organization,…Gender differences in DLB: frequency, clinical presentation and treatment
Objective: To describe demographic and clinical characteristics and use of cholinesterase inhibitors in women and men diagnosed with DLB. Background: DLB seems to be more…Social cognition assessment in progressive supranuclear palsy: The cognitive interface with frontotemporal dementia
Objective: To explore the cognitive profile of PSP patients in tests of social cognition and to compare their performance to patients with behavioural variant frontotemporal…
- « Previous Page
- 1
- …
- 136
- 137
- 138
- 139
- 140
- …
- 207
- Next Page »